Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The mixture supplies a balanced profile of essential and non‑essential amino acids directly into the bloodstream. These amino acids act as building blocks for protein synthesis, replenish nitrogen stores, and support metabolic pathways, thereby promoting tissue repair, immune function, and overall metabolic stability in patients receiving intravenous nutrition.

The dose of Kabiven is individualized and set by the prescribing clinician. Dosing depends on factors such as the patient’s weight, clinical condition, nutritional needs, renal and hepatic function, and laboratory parameters. Healthcare professionals calculate the appropriate volume and rate to achieve the desired protein and nitrogen balance.

Safety data for Kabiven in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefits to the mother outweigh any possible risks to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Kabiven, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain handling if needed—and the necessary import documentation.

Kabiven offers a comprehensive amino acid profile that matches the composition of human plasma proteins, which can be advantageous over formulations with limited amino acid spectra. Compared with generic amino acid mixtures, Kabiven is manufactured under EU GMP standards, providing consistent quality and sterility, though clinical choice ultimately depends on patient needs and institutional protocols.

Kabiven must be stored at 2‑8 °C in a refrigerator. Keep the container in its original packaging, protect it from light, and avoid freezing or shaking the solution. Before use, inspect the vial for particulate matter or discoloration, and discard any product that appears compromised.

Kabiven is administered intravenously as a sterile solution for injection. It is typically infused through a central venous catheter or a peripheral line, following the prescribing clinician’s instructions regarding infusion rate, total volume, and compatibility with other intravenous fluids or medications.

The most serious risks include anaphylactic reactions, metabolic acidosis, and renal dysfunction. These events are rare but require immediate medical attention. Monitoring of vital signs, blood chemistry, and renal function throughout therapy helps detect and manage such complications promptly.

Kabiven should be avoided in patients with known hypersensitivity to any of its amino acid components, those with uncontrolled hyperkalemia, severe metabolic disorders that could be worsened by amino acid infusion, or individuals for whom the risk of precipitation with calcium‑containing solutions cannot be mitigated.